PEA supplements may reduce joint discomfort: Study Two weeks of supplementation with palmitoylethanolamide, an endocannabinoid-like molecule with potent anti-inflammatory properties, may reduce joint discomfort and improving quality of life in adults, says a new study.
Daily supplementation with 350 mg of Gencor’s branded PEA ingredient Levagen+ was associated with reductions in joint pain in the morning and the evening in healthy adults, according to data published in the
International Journal of Nutrition and Food Sciences.
“The safety profile of PEA has been well researched for over 50 years and evidence suggests that doses up to 1,200 mg/day have no harmful effects,” wrote researchers from University of Queensland, RDC Clinical, and the University of Sydney.
Gencor launches Caralluma fimbriata extract for stress and anxiety Gencor is offering a new ingredient for the growing stress management category with the launch of its Calmaluma-branded Caralluma fimbriata extract.
Caralluma fimbriata is a cactus-like plant with a long history of use in India, where it is grown as a vegetable and is used as an ingredient in curries and chutneys. It was also traditionally used by local tribes to ward off hunger when going into the hills or woods for long stretches of time.
Gencor has been supplying the US market with
C. fimbriata extracts since 2006 when it launched the Slimaluma-branded ingredient for weight management applications.